Ragosa Mark

Chief Financial Officer

OtherM

US·SEC (Form 4)

Kiniksa Pharmaceuticals, Ltd.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by Ragosa Mark, Chief Financial Officer. Insider active across 1 companies, notably Kiniksa Pharmaceuticals, Ltd.. Aggregated, 3 reports have been published. Regulator: SEC (Form 4). The full history is openly available.

Declarations3 total

Executives◇OptionsKKiniksa Pharmaceuticals, Ltd.27SEC

R

Ragosa MarkCHIEF FINANCIAL OFFICER

991 shares

Class A Common Share

SEC:0001415889-22-004316:0·26 Apr 2022

SEC ↗

Executives◇OptionsKKiniksa Pharmaceuticals, Ltd.24SEC

R

Ragosa MarkCHIEF FINANCIAL OFFICER

3,019 shares

Class A Common Share

SEC:0001415889-22-003284:0·21 Mar 2022

SEC ↗

Executives◇OptionsKKiniksa Pharmaceuticals, Ltd.24SEC

R

Ragosa MarkChief Financial Officer

872 shares

Class A Common Share

SEC:0001179110-22-002325:0·16 Mar 2022

SEC ↗

3 of 3 declarations

About Ragosa Mark

Mark Ragosa is the Chief Financial Officer of Kiniksa Pharmaceuticals, Ltd. In this role, he oversees the company's financial management, including financial planning and investment strategy. His expertise is crucial for Kiniksa's growth and financial viability.